LATEST MANUSCRIPTS IN Research and Practice in Thrombosis and Haemostasis
Yuto Nakajima, Kenichi Ogiwara, Keito Inaba, Takehisa Kitazawa, Keiji Nogami. NXT007-mediated hemostatic potential is suppressed by activated protein C-catalyzed inactivation of activated factor V.Research and practice in thrombosis and haemostasis. 2024, 8 (1): 102271
Baptiste Panaget, Jordan Wimmer, Delphine Rolland, Laurent Mauvieux, Laurent Sattler, Agathe Herb. Factor V Leiden interferes with protein S activity assay.Research and practice in thrombosis and haemostasis. 2023, 7 (8): 102234
Jessica Garcia, Matthew R Hammer, Ayesha Zia. Serious bleeds in pediatric persons with hemophilia A on emicizumab prophylaxis.Research and practice in thrombosis and haemostasis. 2023, 7 (8): 102238
Bethany Samuelson Bannow, Mary Cushman. Sex Matters: Policy on Reporting Sex as a Biological Variable at Research and Practice in Thrombosis and Hemostasis.Research and practice in thrombosis and haemostasis. 2023, 7 (8): 102256
Hope P Wilson, Maua Mosha, Brian Branchford, Julie Jaffray, Emily Krava, Amy Stillings, Jeffrey Lebensburger, Neil A Goldenberg. Corrigendum to ' Recurrent venous thromboembolism in hospitalized children with a history of prior venous thromboembolism: a report from the Children's Hospital-Acquired Thrombosis Consortium' [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 5, July 2023, 102139].Research and practice in thrombosis and haemostasis. 2023, 7 (8): 102259
Alexandra Yakusheva, Alexandre Slater, Bernard Payrastre, Cédric Garcia, Giorgia D'Italia, Harriet Allan, Judith M E M Cosemans, Matthew Harper, Meinrad Gawaz, Paul Armstrong, Sara Troitiño, Silvia Maria Grazia Trivigno, Ulhas P Naik, Yotis A Senis. Illustrated Abstracts of the 5 EUPLAN International Conference.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102140
Karlyn A Martin, Kenzie A Cameron, Madison J Lyleroehr, Jeffrey A Linder, Matt O'Brien, Lisa R Hirschhorn. Venous thromboembolism prevention in cancer care: implementation strategies to address underuse.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102173
Emna Hammami, Laure Stiel, Clément Palpacuer, Inès Harzallah. Heparin monitoring during extracorporeal membrane oxygenation: the effect of dextran sulfate on anti-Xa assay.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102196
Orly Leiva, Jean M Connors, Nathan T Connell, Jeffrey S Berger. Acute myocardial infarction in von Willebrand disease: characteristics and outcomes.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102198
Evelien S van Hoorn, Hester F Lingsma, Marjon H Cnossen, Samantha C Gouw. Patient-relevant health outcomes for von Willebrand disease, platelet function disorders, and rare bleeding disorders: a Delphi study.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102201
Anna L Parks, Masarret Fazili, Valerie Aston, T Flint Porter, D Ware Branch, Scott C Woller, Gregory L Snow, Scott M Stevens. Excluding pregnancy-associated deep vein thrombosis with whole-leg ultrasound.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102202
Amanda T Walborn, Anna Heath, Matthew D Neal, Ryan Zarychanski, Lucy Z Kornblith, Beverley J Hunt, Lana A Castellucci, Judith S Hochman, Patrick R Lawler, Jonathan D Paul. Effects of inflammation on thrombosis and outcomes in COVID-19: secondary analysis of the ATTACC/ACTIV-4a trial.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102203
Alexis Texier, Peter J Lenting, Cécile V Denis, Stéphanie Roullet, Olivier D Christophe. Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102204
Matthew S Hindle, Lih T Cheah, Daisie M Yates, Khalid M Naseem. Preanalytical conditions for multiparameter platelet flow cytometry.Research and practice in thrombosis and haemostasis. 2023, 7 (7): 102205